ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,545,662, issued on Feb. 10, was assigned to XinThera Inc. (Foster City, Calif.).
"MK2 inhibitors and uses thereof" was invented by Lynnie Trzoss (San Diego), Qing Dong (San Diego), Stephen W. Kaldor (San Diego) and Robert L. Hoffman (San Diego).
According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are MK2 inhibitors of Formula (II) and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of autoimmune disorders, chronic inflammatory disorders, acute inflammatory disorders, auto-inflammatory disorders, fibrotic disorders, metabolic disorders, neoplastic disorders, and cardiov...